来源：智通财经 "港股最大的优势就是便宜。"近日，国海富兰克林基金权益投资总监赵晓东在接受智通财经采访时表 示，港股目前估值处于低位，且大部分大企业注重股东回报，在分红、回购方面更为积极，公司治理也 更为规范，"当下最显眼的机会在港股。" 从资金面看，赵晓东认为，南下资金持续流入成为港股重要支撑，尤其在境内低利率环境下，港股高分 红资产吸引力凸显。若美国降息周期开启或人民币进入升值通道，港股有望迎来进一步的估值修复动 力。 展望未来，赵晓东认为两大外部变量可能进一步提振港股：一是若美国开启降息周期，有望带动全球资 金回流港股市场；二是若人民币进入升值通道，则以人民币计价的资产吸引力将上升，尤其有利于现金 流稳定的高分红标的。 当前为地产行业逆向布局的窗口期 针对市场普遍谨慎的地产行业，赵晓东认为其虽仍面临基本面压力——房价下行、供给过剩及政策对二 手市场的冲击尚未完全消散，但行业已处于底部区域，反而提供了逆向布局的窗口。他预计，明年一季 度或将迎来稳定地产的政策，其目标在于稳住市场信心，而非助推房价上涨。 在具体配置方向上，赵晓东当前重点关注港股中的地产、银行及互联网板块。 他指出，地产行业目前已处于底部区域 ...

Core Viewpoint - The establishment of the E Fund CSI Hong Kong Stock Connect High Dividend Investment ETF reflects a trend among public fund institutions to increase their investment in Hong Kong-themed funds during a market adjustment phase, indicating optimism about the future performance of the Hong Kong stock market [1][2]. Group 1: Fund Activity - In December, 21 public fund institutions have submitted applications for a total of 28 Hong Kong-themed funds, covering sectors such as technology, dividends, consumption, internet, and healthcare [2]. - Several Hong Kong-themed funds have chosen to end their fundraising periods early, such as the Pengyang Hong Kong Stock Connect Selected Mixed Fund, which advanced its deadline by over a month [2]. - The pace of new fund establishment and investment has accelerated, with the E Fund ETF completing its fundraising on December 17 and announcing its establishment on December 23 [2]. Group 2: Market Outlook - Analysts believe that the actions of public fund institutions reflect a recognition of the Hong Kong stock market's value as a key asset class in China, with expectations for a dual boost in fundamentals and valuations in the future [3]. - The Hong Kong stock market has been in a phase of adjustment since October, with external disturbances causing fluctuations, but macroeconomic fundamentals are seen as crucial for a broader market recovery [3]. - Looking ahead, it is anticipated that Hong Kong's earnings will bottom out in 2025, with significant revenue and profit growth expected in 2026 [3]. Group 3: Investment Opportunities - The focus on structural investment opportunities is emphasized, particularly in high-dividend assets and the technology sector, which are expected to have substantial upward potential [4]. - The appeal of Hong Kong high-dividend assets is increasing due to their attractive yields and lower volatility, especially in a declining interest rate environment [4]. - The consumption sector is also expected to receive significant policy support, with current valuations at relatively low levels, indicating potential for medium to long-term growth [4].

Economic Indicators - The core CPI in the US increased by 2.6% year-on-year in November, which is lower than the market expectation of 3% [19] - Non-farm employment in the US rose by 64,000 in November, exceeding the market expectation of 50,000; however, the unemployment rate unexpectedly increased to 4.6%, the highest since September 2021 [19] - Federal Reserve officials indicated that with a weakening job market and controlled inflation, there is significant room for interest rate cuts [19] Capital Flows - Southbound capital flow returned with an inflow of HKD 16.27 billion in one week, compared to an outflow of HKD 3.44 billion the previous week [19] - According to EPFR data, active foreign capital saw an outflow of USD 640 million as of last Wednesday, compared to an outflow of USD 220 million the previous week; however, passive foreign capital accelerated inflows, with USD 3.43 billion entering Hong Kong stocks in one week, up from USD 900 million the previous week [19] Market Outlook - Galaxy Securities noted that with the Bank of Japan's recent decisions and a slightly more dovish expectation from the Federal Reserve, external risks are narrowing, suggesting that Hong Kong stocks may experience a volatile upward trend [22] - The technology sector remains a long-term investment focus, with valuations having corrected after previous adjustments, and is expected to rebound due to multiple favorable factors [22] - The consumer sector is anticipated to receive substantial policy support, with current valuations at relatively low levels; attention should be paid to the implementation of policies and improvements in consumer data [22] Index Information - The National Index for Hong Kong Stock Connect Technology selects 30 leading technology companies based on market capitalization, R&D investment, and revenue growth, including major players like Tencent, Alibaba, Xiaomi, Meituan, SMIC, and BYD [2][7] - The index requires constituent stocks to have a compound revenue growth rate exceeding 10% over the past two years or an R&D expense ratio above 5%, balancing scale and growth potential [7] - The index has a flexible sample adjustment mechanism, with quarterly adjustments to maintain competitiveness [7]

Group 1 - The Hong Kong stock market opened higher on December 23, with the Hang Seng Index rising by 0.29%, the Hang Seng Tech Index up by 0.14%, and the China Enterprises Index increasing by 0.29% [1] - The technology sector remains a long-term investment focus, with valuations having declined after previous adjustments, and is expected to rebound due to multiple favorable factors [1] - The consumer sector is anticipated to receive significant policy support, with current valuations at relatively low levels, indicating substantial medium to long-term upside potential [1] Group 2 - The launch of a new product by Heytea in collaboration with Pop Mart's IP "Starry People" saw over 100 orders within 2 minutes of release, leading to busy conditions in multiple stores in Beijing and a temporary halt on online orders [1] - After experiencing a one-sided rise in September, the Hong Kong stock market has undergone a period of adjustment since October, influenced by fluctuating overseas macro expectations [1] - Analysts suggest that the current environment presents a notable year-end trading window for the Hong Kong market, driven by continued capital inflow, recovery in profit expectations, and improvements in the macro environment [1]

Market Overview - The Hong Kong stock market opened higher on December 22, with the Hang Seng Index rising by 0.41% to 25,795.94 points, the Hang Seng Tech Index increasing by 0.61% to 5,512.54 points, and the State-Owned Enterprises Index up by 0.49% to 8,944.74 points [1] - Major technology stocks mostly rose, with Alibaba up by 0.48%, Tencent Holdings up by 0.98%, and Meituan up by 1.46% [1] - The smart driving concept stocks saw significant gains, with Xiaoma Zhixing rising over 6% [1] - Gold stocks experienced a general increase, with Lingbao Gold rising over 2% [1] - Chip stocks were active, with SMIC rising over 1% [1] Company News - SF Holding (06936.HK) reported a total revenue of 27.173 billion yuan for November, a year-on-year increase of 7.85%, with express logistics revenue growing by 9.88% and business volume increasing by 20.13% [2] - Capital Investment (02324.HK) expects to achieve an unaudited consolidated net profit of approximately 115 million to 140 million HKD for the fiscal year ending September 30, 2025, marking a turnaround from losses due to improved performance in listed equity investments [2] - Tianqi Lithium (09696.HK) announced the completion of the third phase of its chemical-grade lithium concentrate expansion project [3] - Qingdao Port (06198.HK) plans to purchase two assets from the cruise port development for the Qingdao Shipping Financial Center [4] - CanSino Biologics (06185.HK) has initiated Phase I clinical trials for the DTCP–HIb–MCV4 combined vaccine [5] - China National Nuclear Corporation's subsidiary, CNNC Haidewei, received clinical approval for BNCT boron drugs [6] Investment Insights - CITIC Securities noted that after a period of single-sided growth in September, the Hong Kong stock market has experienced fluctuations since October, with quality assets entering a high-value zone [14] - Changjiang Securities highlighted that the approval of the first batch of L3-level vehicles marks a new stage for smart connected vehicles in mass production, suggesting investment opportunities in smart driving algorithm providers and related hardware suppliers [14][15]

Group 1: QDII Fund Performance - The performance of QDII products has shown significant differentiation over the past year, with the top-ranking fund, Huatai-PineBridge Hong Kong Advantage Selected Mixed A, achieving a net value increase of 111%, leading the bottom-ranking products by 124.6 percentage points [1] - As of December 17, the average net value increase for QDII funds over the past year was 20.9%, with notable performers including Huatai-PineBridge Hong Kong Advantage Selected Mixed A (111%), Chuangjin Hexin Global Pharmaceutical Biotechnology Stock A (86.54%), and GF Zhongzheng Hong Kong Innovation Medicine (74.14%) [1] - The top ten funds in the QDII performance rankings are primarily Hong Kong stock funds, many of which have significant holdings in the Hong Kong pharmaceutical sector [1] Group 2: Market Trends and Analysis - The Hong Kong innovative pharmaceutical sector has recently experienced a significant adjustment, leading to a decline in the net value of related products, attributed to seasonal outflows of southbound funds and a decrease in the holding ratio of leading pharmaceutical stocks in the Hong Kong Stock Connect [2] - Despite the recent downturn, the fundamental outlook for the innovative pharmaceutical industry remains positive, with ongoing trends of innovative drugs going global, benefiting the entire supply chain, including upstream CXO and research services [2] - The performance of Saudi-themed ETFs and oil-related products has been poor, with two Saudi-themed products seeing net value declines of over 10% in the past year, while several oil-focused funds also reported negative returns [2] Group 3: Future Outlook - Looking ahead to global asset allocation for the next year, there is a belief that Hong Kong stocks still possess significant low valuation advantages amidst high valuations in most global markets, with expectations of orderly capital inflows as the external environment stabilizes and the Chinese economic outlook improves [2]

Group 1: Regulatory Actions - The National Internet Information Office and the China Securities Regulatory Commission have taken action to address false information related to the capital market, targeting accounts that spread rumors and illegally recommend stocks [1] Group 2: Market Developments - The Shenzhen Stock Exchange and China Securities Depository and Clearing Corporation have issued a notice to support foreign institutional investors in conducting bond repurchase transactions, effective immediately [2] - The foreign exchange market in China has maintained stability, with a surplus of $15.7 billion in November, consistent with October levels [3] Group 3: Company News - China Shenhua plans to acquire 100% equity stakes in several subsidiaries of the State Energy Group for a total transaction price of 133.598 billion yuan [7] - Nanjing Commercial Travel has terminated its major asset restructuring plan and withdrawn its application, stating that this will not significantly impact its business or financial status [6] - Tianpu Co. announced a public tender offer for 33.52 million shares, representing 25% of its total share capital, at a price of 23.98 yuan per share [5] - Dongfang Zhizao's controlling shareholder is undergoing a change, with a share transfer agreement signed for 14.33% of the company's total shares [8] - Jinggong Technology plans to invest 426 million yuan in a new intelligent manufacturing base in Wuhan, which will enhance its production capabilities [9] - Bohai Chemical has decided to terminate its major asset restructuring plan due to a lack of agreement on key terms [10]

Group 1 - The first Hong Kong stock information technology ETF, 159131, is set to shine, focusing on the "Hong Kong stock chip" industry chain [1][6] - The Hong Kong internet ETF, 513770, overlaps with major internet giants in Hong Kong and has a scale of over 10 billion [1] - The Hong Kong stock innovation drug ETF, 520880, is designed to cover the innovative drug sector with 100% pure innovation [2][6] Group 2 - The Hong Kong large-cap 30 ETF, 520560, is positioned to capture both high dividends and low volatility advantages [2][6] - The Hong Kong stock medical ETF, 159137, aims to comprehensively cover leading companies in the medical sector [2][6] - The Hong Kong stock automotive ETF, 520780, is set to be launched, focusing on scarce leading automotive companies in Hong Kong [2][6]

Core Viewpoint - The Hong Kong stock market is experiencing fluctuations, particularly with the Hang Seng Technology Index declining, yet there is strong investor confidence in the future performance of Hong Kong stocks, especially in the technology sector [1] Group 1: Market Performance - The Hong Kong stock market is undergoing adjustments, with the Hang Seng Technology Index falling again [1] - The Hong Kong Technology 30 ETF (513160) saw a drop of over 1% during trading, influenced by market conditions [1] Group 2: Fund Flows - Despite market volatility, the Hong Kong Technology 30 ETF (513160) has attracted significant capital, with a net inflow of approximately 600 million yuan over the past nine trading days, bringing the total fund size to 5.682 billion yuan [1] Group 3: Future Outlook - Analysts believe that the combination of a loose liquidity environment and favorable policies will likely lead to an upward trend in Hong Kong stocks [1] - The technology sector is viewed as a long-term investment focus, with valuations having adjusted downwards, suggesting potential for rebound due to multiple positive factors [1] Group 4: Investment Accessibility - Direct investment in multiple Hong Kong technology stocks can be complex and has high entry barriers for ordinary investors [1] - The Hong Kong Technology 30 ETF (513160) offers a simplified investment option, allowing investors to purchase a basket of quality Hong Kong technology companies, with additional access through linked funds (A class: 024037; C class: 024038) [1]

经历了2021至2023年的持续三年低迷行情后，2024年以来港股市场已迈入"业绩+估值"双击的行情。 年初受大模型推出及AI商业化落地催化，中国资产重估行情启动，港股市场领衔上行，虽然四季度以 来港股市场有望承压，但年初至今的累计涨幅仍然亮眼，在全球主流市场指数中名列前茅，成功逆袭！ 恒生指数涨29.6%，其中的港股通标的更是"青出于蓝胜于蓝"，恒生港股通指数涨幅高达34.6%！ 今日，跟踪恒生港股通指数的恒生港股通ETF（520820）重磅上市！恒生港股通ETF（520820）囊括港 股重点板块稀缺资产，轻松布局港股互联网、创新药、新消费等优质龙头！ 数据截至2025.12.14 那么历经两年的估值修复后，港股市场在2026年又将有何表现呢？"指数投资"趋势下，又有哪些新工具 值得关注呢？ 【春山可望？2026年港股研判："乘势而上、迈向新高度"】 中信证券从多个维度剖析了港股市场2026年的配置价值，其中指出： 估值维度，当前港股仍是全球主要市场中的估值洼地，而计算当前的恒生指数ERP仍高达到5.7%。业绩 来看，当前Bloomberg一致预期显示恒生指数的2026E净利润同比增长8.5%。随着港股基本 ...